Moreover, tirzepatide outperformed semaglutide when it came to weight loss, with tirzepatide doses of 15 mg, 10 mg, and 5 mg delivering notable reductions in body weight (-10.96 Kg, -8.75 Kg, and -6.16 Kg, respectively) compared to semaglutide (-5.24 Kg, -4.44 Kg, and -2.72 Kg for semaglutide at 2.0, 1.0, and 0.5 mg, respectively)
These agents work in the same pathway as DPP-4 inhibitors but are generally considered more potent
What to Avoid While Using the Medication: Minimize alcohol consumption, and be cautious about mixing with certain diabetes medications without talking to your healthcare provider
Fatty liver disease: Could reduce cell damage associated with fatty liver disease
Cytochrome c release assay Cells were fractionated to obtain cytoplasmic and mitochondria-enriched fractions using Dounce homogenization and differential centrifugation as per the Abcam cytochrome c release kit (ab65311)